Table 1.
Author | Income group | Race | Population | Sample size | HBV infection (n/%) | ||||
Total | A, non-A* | B, non-B* | AB, non-AB* | O, non-O* | |||||
Terrier et al 29 | High | Caucasian | Blood donors | 5968 | 55/0.92 | 9/0.37, 46/1.31 | 4/0.66, 51/0.95 | 2/0.78, 53/0.93 | 40/1.51, 15/0.45 |
Leski et al 30 | High | Caucasian | Patients | 155 | 34/21.94 | 16/23.19, 18/20.93 | 4/28.57, 30/21.28 | 0/0, 34/22.67 | 14/20.9, 20/22.73 |
Szmuness et al 19 | High | Caucasian | Blood donors | 8096 | 177/2.19 | 61/2.06, 116/2.26 | 25/2.21, 152/2.18 | 13/3.57, 164/2.12 | 78/2.14, 99/2.23 |
Zuberi and Lodi31 | Lower middle | Caucasian | Blood donors | 1111 | 38/3.42 | 9/3.36, 29/3.44 | 5/1.23, 33/4.69 | 2/3.64, 36/3.41 | 22/5.77, 16/2.19 |
Vale et al 32 | Lower middle | African | General | 836 | 40/4.78 | 18/5.61, 22/4.27 | 6/4.11, 34/4.93 | 5/4.59, 35/4.81 | 11/4.23, 29/5.03 |
Moore et al 33 | Low | Caucasian | Blood donors | 14 916 | 495/3.32 | 127/3.48, 368/3.27 | 103/3.21, 392/3.35 | 17/3.1, 478/3.33 | 248/3.3, 247/3.33 |
Szmuness et al 20 | High | Caucasian | Blood donors | 51 019 | 58/0.11 | 22/0.11, 36/0.11 | 5/0.08, 53/0.12 | 4/0.16, 54/0.11 | 27/0.12, 31/0.11 |
Lenka et al 34 | Lower middle | Caucasian | Blood donors | 500 | 24/4.8 | 12/9.3, 12/3.23 | 8/4.08, 16/5.26 | 0/0, 24/5.25 | 4/3.03, 20/5.43 |
Nath et al 35 | High | Caucasian | Blood donors | 1585 | 68/4.29 | 22/4.03, 46/4.44 | 9/3.35, 59/4.48 | 3/4.17, 65/4.30 | 34/4.87, 34/3.83 |
Kulkarni et al 36 | Lower middle | African | Blood donors | 1860 | 165/8.87 | 51/13.11, 114/7.85 | 17/3.11, 148/11.27 | 18/18.75, 147/8.33 | 79/9.54, 86/8.33 |
Naidu and Rajyalakshmi37 | Lower middle | Caucasian | Blood donors | 1029 | 145/14.09 | 49/20.08, 96/12.40 | 42/12.39, 103/14.93 | 11/17.74, 134/13.86 | 43/11.20, 102/15.81 |
Sebastian et al 38 | High | Asian | Blood donors | 3276 | 134/4.09 | 30/4.17, 104/4.08 | 30/3.50, 104/4.30 | 10/4.76, 124/4.04 | 64/4.30, 70/3.91 |
Zhu et al 39 | Upper middle | Asian | Blood donors | 8683 | 153/1.76 | 44/1.62, 109/1.83 | 30/1.37, 123/1.89 | 18/2.59, 135/1.69 | 61/1.98, 92/1.64 |
Joshi and Ghimire40 | Low | Asian | General | 613 | 17/2.77 | 4/2.09, 13/3.08 | 5/2.86, 12/2.74 | 1/2.13, 16/2.83 | 7/3.5, 10/2.42 |
El-Gilany and El-Fedawy41 | Lower middle | Caucasian | Blood donors | 2157 | 93/4.31 | 27/3.42, 66/4.87 | 19/3.85, 74/4.45 | 12/5.88, 81/4.15 | 35/5.23, 58/3.90 |
Behal et al 21 | Lower middle | Caucasian | Blood donors | 20 000 | 450/2.25 | 106/2.30, 344/2.24 | 174/2.34, 276/2.20 | 38/1.87, 412/2.29 | 132/2.23, 318/2.26 |
Rifat-uz-Zaman42 | Lower middle | Caucasian | General | 1464 | 93/6.35 | 5/3.01, 88/6.90 | 35/6.63, 58/6.20 | 23/6.99, 70/6.17 | 30/6.80, 63/6.16 |
Dirisu et al 43 | Lower middle | African | Blood donors | 427 | 200/46.84 | 32/45.71, 168/47.06 | 39/52, 161/45.74 | 1/33.33, 199/46.93 | 128/45.88, 72/48.65 |
Saeed Anwar et al 44 | Lower middle | Caucasian | Blood donors | 16 695 | 467/2.80 | 103/2.60, 364/2.86 | 139/2.31, 328/3.07 | 17/2.64, 450/2.80 | 208/3.42, 259/2.44 |
Omar et al 45 | Upper middle | Caucasian | Blood donors | 430 | 71/16.51 | 15/12.5, 56/18.06 | 21/21.43, 50/15.06 | 3/5.36, 68/18.18 | 32/20.51, 39/14.23 |
Tyagi and Tyagi46 | Lower middle | Caucasian | Blood donors | 6000 | 95/1.58 | 27/1.87, 68/1.49 | 27/1.27, 68/1.75 | 9/1.98, 86/1.55 | 32/1.62, 63/1.57 |
Sethi et al 47 | Lower middle | Caucasian | Blood donors | 7884 | 50/0.63 | 15/0.60, 35/0.65 | 10/0.41, 40/0.74 | 11/1.28, 39/0.56 | 14/0.68, 36/0.62 |
Mohammadali and Pourfathollah18 | Upper middle | Caucasian | Blood donors | 2 028 068 | 7839/0.39 | 2553/0.40, 5286/0.38 | 1952/0.40, 5887/0.38 | 627/0.41, 7212/0.38 | 2707/0.36, 5132/0.40 |
Nigam et al 48 | Lower middle | Caucasian | Blood donors | 4128 | 40/0.97 | 12/1.17, 28/0.90 | 11/0.75, 29/1.09 | 2/0.50, 38/1.02 | 15/1.22, 25/0.86 |
Lao et al b16 | High | Asian | General | 78 705 | 7786/9.89 | 2038/9.90, 5748/9.97 | 1991/9.60, 5795/10.00 | 468/9.11, 7318/9.95 | 3289/10.20, 4497/9.68 |
Zhao et al 49 | Upper middle | Asian | Patients | 500 | 66/13.20 | 17/11.18, 49/14.71 | 16/9.82, 50/14.84 | 15/16.67, 51/12.44 | 18/18.95, 48/11.85 |
Siransy et al 50 | Upper middle | African | Blood donors | 59 514 | 4119/6.92 | 947/7.15, 3172/6.86 | 941/6.78, 3178/6.96 | 187/6.77, 3932/6.93 | 2044/6.9, 2075/6.94 |
Navolan et al 51 | Upper middle | Caucasian | General | 1385 | 33/2.38 | 15/2.42, 18/2.37 | 7/3.11, 26/2.24 | 4/3.54, 29/2.28 | 7/1.64, 26/2.71 |
Bisetegen et al 52 | Low | African | Blood donors | 390 | 37/9.49 | 7/6.73, 30/10.49 | 10/12.99, 27/8.63 | 2/22.22, 35/9.19 | 18/9, 19/10 |
Abate and Wolde27 | Low | African | Blood donors | 6827 | 647/9.48 | 114/5.66, 533/11.10 | 54/5.45, 593/10.16 | 9/4.27, 638/9.64 | 470/13.02, 177/5.50 |
Bharadva et al 53 | Lower middle | Caucasian | Blood donors | 41 909 | 237/0.57 | 62/0.63, 175/0.55 | 85/0.58, 152/0.56 | 22/0.55, 215/0.57 | 68/0.51, 169/0.59 |
Naseri et al 54 | Upper middle | Caucasian | Blood donors | 228 409 | 640/0.28 | 208/0.29, 432/0.28 | 180/0.34, 460/0.26 | 42/0.24, 598/0.28 | 210/0.25, 430/0.30 |
Memon et al 55 | Lower middle | Caucasian | Blood donors | 4683 | 66/1.41 | 15/1.37, 51/1.42 | 21/1.53, 45/1.36 | 9/2.94, 57/1.30 | 21/1.10, 45/1.63 |
Liu et al 17 | Upper middle | Asian | General | 3 827 125 | 215455/5.63 | 64811/5.55, 150644/5.71 | 58286/5.18, 157169/5.82 | 18707/5.06, 196748/5.69 | 73651/6.34, 141804/5.32 |
Batool et al 56 | Lower middle | Caucasian | Blood donors | 41 084 | 969/2.36 | 321/2.72, 648/2.22 | 289/2.21, 680/2.43 | 82/2.13, 887/2.38 | 277/2.24, 692/2.41 |
Ngassaki-Y et al 57 | Upper middle | African | Blood donors | 4744 | 81/1.71 | – | – | – | 34/1.22, 47/2.41 |
Fu et al 58 | Upper middle | Asian | Patients | 2000 | 389/19.45 | 105/21.43, 284/18.81 | 89/18.94, 300/19.61 | 59/21.85, 330/19.08 | 136/17.66, 253/20.57 |
Nkansah et al 59 | Lower middle | African | Blood donors | 3306 | 342/10.34 | 48/11.76, 294/10.21 | 63/9.35, 279/10.67 | 1/3.33, 341/10.47 | 230/10.48, 112/10.07 |
*The number of HBV infected people in the X blood group/HBV prevalence (%) in the X blood group; the number of HBV-infected people in the non-X blood group/HBV prevalence (%) in the non-X blood group.
HBV, Hepatitis B virus.